Top Pharmaceuticals companies in Sweden by Total Assets

This ranking features the top 38 Pharmaceuticals companies in Sweden ranked by Total Assets, totaling a Total Assets of USD 8.91 B, for July 04, 2025.

#	Name	Market Capitalization Share Price Year-To-Date (YTD) return Price to Earnings Ratio (P/E) Revenue Revenue Year-on-Year (YoY) growth Operating Income EBIT EBITDA Free Cash Flow Dividend Yield Free Cash Flow Yield Total Liabilities Cash and Short-Term Investments	Stock Price	Change	Price (30 days)	52W low/high	Sector

Items per page

Frequently Asked Questions

Which Pharmaceuticals company in Sweden has the highest Total Assets ?

The Pharmaceuticals company in Sweden with the highest Total Assets is Swedish Orphan Biovitrum AB (publ) (Stockholm Stock Exchange: SOBI.ST) at USD 6.79 B.

Which Pharmaceuticals company in Sweden has the lowest Total Assets ?

The Pharmaceuticals company in Sweden with the lowest Total Assets is Carbiotix AB (Stockholm Stock Exchange: CRBX.ST) at None.

What are the top 10 Pharmaceuticals companies in Sweden by Total Assets ?

The top 10 Pharmaceuticals companies in Sweden by Total Assets are Swedish Orphan Biovitrum AB (publ), Vimian Group AB (publ), Camurus AB (publ), BioGaia AB (publ), Magle Chemoswed Holding AB (publ), Xspray Pharma AB (publ), Egetis Therapeutics AB (publ), Mendus AB (publ), Orexo AB (publ) and Devyser Diagnostics AB (publ).

What are the bottom 10 Pharmaceuticals companies in Sweden by Total Assets ?

The bottom 10 Pharmaceuticals companies in Sweden by Total Assets are Carbiotix AB, Chordate Medical Holding AB (publ), BioArctic AB (publ), BrainCool AB (publ), Aptahem AB (publ), Alzinova AB (publ), aXichem AB, AlzeCure Pharma AB (publ), BioInvent International AB (publ) and Diamyd Medical AB (publ).